Dow Jones

39,112.16

-0.76%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Scholar Rock Holdings Corporation (SRRK)
Scholar Rock Holdings Corporation (SRRK) Noticias

SRRK

Scholar Rock (SRRK)

Scholar Rock Holdings Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SRRK

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
24/06/2024	06:00	Business Wire	Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal	NASDAQ:SRRK	Scholar Rock Holdings Corporation
18/06/2024	16:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SRRK	Scholar Rock Holdings Corporation
18/06/2024	15:15	Business Wire	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SRRK	Scholar Rock Holdings Corporation
03/06/2024	15:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRRK	Scholar Rock Holdings Corporation
03/06/2024	15:00	Business Wire	Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting	NASDAQ:SRRK	Scholar Rock Holdings Corporation
28/05/2024	07:00	Business Wire	Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:SRRK	Scholar Rock Holdings Corporation
22/05/2024	06:00	Business Wire	Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity	NASDAQ:SRRK	Scholar Rock Holdings Corporation
20/05/2024	07:00	Business Wire	Scholar Rock to Participate in Upcoming Investor Conferences	NASDAQ:SRRK	Scholar Rock Holdings Corporation
14/05/2024	07:00	Business Wire	Scholar Rock to Host Investor Day on May 22, 2024	NASDAQ:SRRK	Scholar Rock Holdings Corporation
07/05/2024	06:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SRRK	Scholar Rock Holdings Corporation
07/05/2024	06:00	Business Wire	Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress	NASDAQ:SRRK	Scholar Rock Holdings Corporation
19/03/2024	06:00	Business Wire	Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress	NASDAQ:SRRK	Scholar Rock Holdings Corporation
15/02/2024	15:30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SRRK	Scholar Rock Holdings Corporation
15/02/2024	07:00	Business Wire	Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer	NASDAQ:SRRK	Scholar Rock Holdings Corporation
06/02/2024	07:00	Business Wire	Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	NASDAQ:SRRK	Scholar Rock Holdings Corporation
23/01/2024	08:02	Dow Jones News	Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab	NASDAQ:SRRK	Scholar Rock Holdings Corporation
23/01/2024	07:00	Business Wire	Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	NASDAQ:SRRK	Scholar Rock Holdings Corporation
04/01/2024	07:00	Business Wire	Scholar Rock Provides Corporate Update and Highlights Priorities for 2024	NASDAQ:SRRK	Scholar Rock Holdings Corporation
19/12/2023	07:00	Business Wire	Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:SRRK	Scholar Rock Holdings Corporation
14/12/2023	17:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SRRK	Scholar Rock Holdings Corporation
07/11/2023	06:15	Business Wire	Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress	NASDAQ:SRRK	Scholar Rock Holdings Corporation
03/11/2023	15:00	Business Wire	Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability	NASDAQ:SRRK	Scholar Rock Holdings Corporation
19/10/2023	07:00	Business Wire	Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting	NASDAQ:SRRK	Scholar Rock Holdings Corporation
16/10/2023	15:15	Business Wire	Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares	NASDAQ:SRRK	Scholar Rock Holdings Corporation
12/10/2023	15:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:SRRK	Scholar Rock Holdings Corporation
11/10/2023	19:57	Business Wire	Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock	NASDAQ:SRRK	Scholar Rock Holdings Corporation
11/10/2023	16:05	Business Wire	Scholar Rock Announces Proposed Public Offering of Common Stock	NASDAQ:SRRK	Scholar Rock Holdings Corporation
11/10/2023	15:44	Business Wire	Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders	NASDAQ:SRRK	Scholar Rock Holdings Corporation
19/09/2023	07:00	Business Wire	Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial	NASDAQ:SRRK	Scholar Rock Holdings Corporation
09/08/2023	15:15	Business Wire	Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress	NASDAQ:SRRK	Scholar Rock Holdings Corporation